CANCER DISCOV 润色咨询

Cancer Discovery

出版年份:2011 年文章数:1175 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2023-09-15 shyhihihi 来自宾夕法尼亚

    投稿命中率:5.0
    经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。
    目前来看cancer cell还是当仁不让的老大哥。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2022-06-02 cindichaw

    顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2023-09-01 ms9508293866653270 来自陕西省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:医学
    经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2021-08-05 千寻1076

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2021-12-29 衣谷

    撰写文章题目有没有技巧?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    文章题目怎么写更好?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2018-07-03 sunliang

    这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表:
    的确是很经典的杂志

    sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2018-06-30 sunliang

    的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表:
    特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去

    bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2018-05-18 bigapple001

    特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0<br>经验分享:感觉cancer cell, cancer discovery和nature cancer 未来会形成三足鼎立之势。<br>目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊!把它排在cancer cell 之前了。希望下半年完成工作,投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:医学<br>经验分享:更偏重临床,不能说不好,但是相比之下,文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量也是顶级,但是目前没有IF,还是放弃改投了。总之,如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮,文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究<span class="quote">sunliang 2018-06-30 00:00:00 发表:<br>的确是很经典的杂志</span>, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志<span class="quote">bigapple001 2018-05-18 22:36:00 发表:<br>特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去</span>, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版 这个杂志基本上都收热点的文章 冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555903, encodeId=d9c4555903dc, content=好想发一篇paper在这个杂志上啊!!<span class="quote">cfjun163 2018-01-09 15:32:00 发表:<br>一年才80多篇文章.肯定不好投啊</span>, beContent=cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed May 09 00:00:00 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2018-05-09 sunliang

    好想发一篇paper在这个杂志上啊!!cfjun163 2018-01-09 15:32:00 发表:
    一年才80多篇文章.肯定不好投啊

    cfjun163 2018-01-09 15:32:00 发表: 一年才80多篇文章.肯定不好投啊

    0

共30条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分